Pediatric Cancer

At the recent AONN+ Annual Conference, Ms Sanborn, Infectious Disease – Host Defense Team Nurse Practitioner at Nationwide Children’s Hospital, provided an in-depth look at the current state of pediatric cancer, highlighting the crucial role of pediatric nurse navigators.

Making art and telling stories with patients can lead to profound healing, according to Sharon Chappell, PhD, breast cancer survivor, author, and educator at Cal State Fullerton.

On December 12, 2019, the FDA issued draft guidance to implement amendments to the Federal Food, Drug, and Cosmetic (FD&C) Act that will facilitate early assessment of studies of molecularly targeted oncology drugs that may be effective in the treatment of pediatric cancers.

Approximately 25% of children, adolescents, and young adults with advanced cancer were eligible for a targeted therapy after genotyping of their tumors in the Pediatric Molecular Analysis for Therapy Choice (MATCH) clinical trial.